Abstract
The mitotic spindle is an important target for cancer chemotherapy. The main protein target for drugs in clinical use is tubulin, the building block of microtubules. In recent years, other proteins of the mitotic spindle have been identified as potential targets for the development of more specific drugs with the hope that these will have fewer side effects than known antimitotics (taxanes, vinca alkaloids). The human genome contains more than 40 members of the kinesin superfamily, with at least 12 of these involved in mitosis and cytokinesis. HsEg5 (also called KSP, kinesin spindle protein), a member of the kinesin-5 family, involved in the formation of the bipolar spindle, is a very promising target for cancer chemotherapy with specific inhibitors in Phase I and II clinical trails. Several successful approaches exist today to screen Eg5 for inhibitors, including phenotype-based assays and simple in vitro assays that explore the intrinsic enzymatic ATPase activity of Eg5. Here, we describe a robust and straightforward in vitro method to rapidly screen Eg5 for inhibitors. The assay can easily be adapted to other mitotic kinesins that may be identified in the future as potential drug targets, or simply to obtain specific kinesin inhibitors for use in “chemical genetics” to study the function of this important class of proteins.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hamel, E. (1996) Antimitotic natural products and their interactions with tubulin. Med. Res. Revs. 16, 207–231.
Kreis, T. and Vale, R. (1999) Guidebook to the Cytoskeletal and Motor Proteins. Oxford University Press, New York.
Wood, K. W., Cornell, W. D., and Jackson, J. R. (2001) Past and future of the mitotic spindle as an oncology target. Curr. Opin. Pharmacol. 1, 370–377.
Miyamoto, D. T., Perlman, Z. E., Mitchison, T. J., and Shirasu-Hiza, M. (2003) Dynamics of the mitotic spindle: potential therapeutic targets. Prog. Cell Cycle Res. 5, 349–360.
Mayer, T. U. (2003) Chemical genetics: tailoring tools for cell biology. Trends Cell Biol. 13, 270–277.
Blangy, A., Lane, H. A., d’Herin, P., Harper, M., Kress, M., and Nigg, E. A. (1995) Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 83, 1159–1169.
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., and Mitchison, T. J. (1999) Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286, 971–974.
Nakazawa, J., Yajima, J., Usui, T., et al. (2003) A novel action of terpendole e on the motor activity of mitotic Kinesin eg5. Chem. Biol. 10, 131–137.
DeBonis, S., Skoufias, D. A., Robin, G., et al. (2004) In vitro screening for inhibitors of the human mitotic kinesin, Eg5, with antimitotic and antitumor activity. Mol. Cancer Ther. 3, 1079–1090.
Cox, C. D., Breslin, M. J., Mariano, B. J., et al. (2005) Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP. Bioorg. Med. Chem. Lett. 15, 2041–2045.
Hotha, S., Yarrow, J. C., Yang, J. G., et al. (2003) A potent small-molecule probe for the dynamics of cell division. Angew. Chem. Int. Ed. Engl. 42, 2379–2385.
Sakowicz, R., Finer, J. T., Beraud, C., et al. (2004) Antitumor activity of a kinesin inhibitor. Cancer Res. 64, 3276–3280.
Sakowicz, R., Berdelis, M. S., Ray, K., et al. (1998) A marine natural product inhibitor of kinesin motors. Science 280, 292–295.
Hopkins, S. C., Vale, R. D., and Kuntz, I. D. (2000) Inhibitors of kinesin activity from structure-based computer screening. Biochemistry 39, 2805–2814.
Yen, T. J., Li, G., Schaar, B. T., Szilak, I., and Cleveland, D.W. (1992) CENP-E is a putative kinetochore motor that accumulates just before mitosis. Nature 359, 536–539.
Nislow, C., Lombillo, V. A., Kuriyama, R., and McIntosh, J. R. (1992) A plusend-directed motor enzyme that moves antiparallel microtubules in vitro localizes to the interzone of mitotic spindles. Nature 359, 543–547.
Hackney, D. D. and Jiang, W. (2001) Assays for kinesin microtubule-stimulated ATPase actvity. Methods Mol. Biol. 164, 65–71.
Funk, C. J., Davis, A. S., Hopkins, J. A., and Middleton, K. M. (2004) Development of high-throughput screens for discovery of kinesin adenosine triphosphate modulators. Anal. Biochem. 329, 68–76.
Andreassen, P. R., Skoufias D. A., and Margolis, R. L. (2004) Analysis of the spindle-assembly checkpoint in HeLa cells. Methods Mol. Biol. 281, 213–225.
Webb, M. R. (1992) A continuous spectrophotometric assay for inorganic phosphate and for measuring phosphate release kinetics in biological systems. Proc. Natl. Acad. Sci. USA 89, 4884–4887.
DeBonis, S., Simorre, J. P., Crevel, I., et al. (2003) Interaction of the mitotic inhibitor monastrol with human kinesin Eg5. Biochemistry 42, 338–349.
Zhang, J. H., Chung, T. D. Y., and Oldenburgh, K. R. (1999). A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screening 4, 67–73.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Kozielski, F., DeBonis, S., Skoufias, D.A. (2007). Screening for Inhibitors of Microtubule-Associated Motor Proteins. In: Zhou, J. (eds) Microtubule Protocols. Methods in Molecular Medicine™, vol 137. Humana Press. https://doi.org/10.1007/978-1-59745-442-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-59745-442-1_14
Publisher Name: Humana Press
Print ISBN: 978-1-58829-642-9
Online ISBN: 978-1-59745-442-1
eBook Packages: Springer Protocols